Products Affected: Stelara (ustekinumab) subcutaneous solution and intravenous infusion Dosing Limitations: Subcutaneous Adult Dosage Regimen (Psoriasis
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor
receive STELARA as an injection under the skin (subcutaneous injection) 8 weeks after the first dose of STELARA, as described below. Adults with psoriasis or psoriatic arthritis, and children 6 years and older with psoriasis or psoriatic arthritis will receive STELARA as an injection under the skin (subcutaneous injection) as described below.
requires additional induction dosing for plaque psoriasis or psoriatic arthritis, as verified by the absence of claims for Stelara in the
Children with plaque psoriasis or psoriatic arthritis who are ages 6 to 17 years old will follow the adult dosing schedule for Stelara. Your child s doctor will determine their Stelara dose
Learn about moderate to severe plaque psoriasis treatment STELARA STELARA is a prescription medicine used to treat: If your doctor feels that you are at
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor
Dosage: (Adults): Plaque Psoriasis: For the treatment of plaque psoriasis, Ustekinumab (Stelara) is administered by subcutaneous injection. The recommended
FOR INITIAL SC THERAPY: The member has received a single induction dose with Stelara Psoriatic Psoriasis pediatrics (6 years of age
Comments